title: Use of rituximab in two unusual antibody-mediated autoimmune disorders.
authors.affiliation: Rheumatology Department, Royal Free Hospital, London NW3 2QG, UK.
authors.forename: Matthew
authors.initials: M
authors.lastname: Adler
authors.forename: Fotini
authors.initials: F
authors.lastname: Soliotis
authors.forename: Sonali
authors.initials: S
authors.lastname: Thakrar
authors.forename: Richard
authors.initials: R
authors.lastname: Stratton
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D000069283:Rituximab; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab